Portfolio company
Neurona Therapeutics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops off-the-shelf regenerative neural cell therapies for patients with drug-resistant epilepsy and other chronic disorders of the central nervous system.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Neumirna Therapeutics
This biotechnology company develops microRNA-based therapies to treat patients with neurological disorders, including drug-resistant epilepsy and Parkinson's disease.
Neurosciences
This company develops precision sodium channel therapeutics to treat patients with neurological conditions such as genetic epilepsy and chronic neuropathic pain.
Savanna Biotherapeutics
This company develops induced pluripotent stem cell-derived microglia cell therapies to treat patients with neurodegenerative diseases and other central nervous system disorders.
BE Therapeutics
This company develops engineered brain and spinal cord tissues to repair central nervous system damage for patients with neurodegeneration, stroke or trauma.
Cadence Neuroscience
This medical device company develops a neural implant platform for treating drug-resistant epilepsy and other neurological disorders in patients.
Neuroplast
This company develops autologous stem cell therapies to treat patients with neurodegenerative diseases including spinal cord injuries and amyotrophic lateral sclerosis.
Cerevel Therapeutics
This biopharmaceutical company develops neuroscience medicines for patients with mental and neurological conditions including schizophrenia, Parkinson's disease and epilepsy.
Corlieve Therapeutics
The company develops gene therapies for patients with refractory temporal lobe epilepsy and other severe neurological disorders.
